Apexigen

About:

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

Website: http://www.apexigen.com

Top Investors: Delian Capital, Decheng Capital, 3E Bioventures, SV Tech Ventures, Oceanpine Capital

Description:

Apexigen is a clinical-stage biopharmaceutical company developing antibody therapeutics for the treatment of cancer. It specializes in new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer.

Total Funding Amount:

$176M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Carlos, California, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)apexigen.com

Founders:

Xiaodong Yang

Number of Employees:

11-50

Last Funding Date:

2023-01-24

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai